Enhanced sensitivity of flow cytometry for routine assessment of minimal residual disease

In a recent paper by Bene and Kaeda,[1][1] technical approaches for minimal residual disease (MRD) assessment are extensively reviewed. PCR-based studies have proved to be 1-log more sensitive than flow cytometry (FC). For this reason, they are increasingly being preferred for MRD analysis,